14
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Systemic vascular resistance during brief withdrawal of angiotensin converting enzyme inhibition in heart failure

, , , , , , , & show all
Pages 245-254 | Published online: 08 Jul 2009

  • Creager MA, Halperin JL, Bernard DB, Faxon DP, Melidossian CD, Gavras H, Ryan TJ. Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure. Circulation 1981; 3:483-9.
  • Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation 1996; 94: 2285-96.
  • Gabrielsen A, Sørensen VB, Pump B, Galatius S, Videbaek R, Bie P, Warberg J, Christensen NJ, Wroblewski H, Kastrup J, Norsk P. Cardiovascular and neuroendocrine responses to water immersion in compensated heart failure. Am J Physiol Heart Circ Physiol 2000; 279: H1931-H40.
  • Goldsmith SR, Hasking GJ, Miller E. Angiotensin II and sympathetic activity in patients with congestive heart failure. J Am Coll Cardiol 1993; 21: 1107-13.
  • Clemson B, Gaul L, Gubin SS, Campsey DM, McConville J, Nussberger J, Zelis R. Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm. J CHn Invest 1994; 93: 684-91.
  • Newby DE, Goodfield NER, Flapan AD, Boon NA, Fox KAA, Webb DJ. Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II. Heart 1998; 80: 134-41.
  • Dibner-Dunlap ME, Smith ML, Kinugawa T, Thames MD. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol 1996; 27: 358-64.
  • Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Pozzi M, Morganti A, Carugo S, Mancia G. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 1997; 96: 1173-9.
  • Goldsmith SR, Francis GS, Levine TB, Cohn JN. Regional blood flow response to orthostasis in patients with congestive heart failure. J Am Coll Cardiol 1983; 1: 1391-5.
  • Francis GS, McDonald KM. Congestive heart failure: mechanisms, physiologic derangement, and therapy. In: Singh BN, Dzau VJ, Vanhoutte PM, Woosley RL, editors. Cardiovascular pharmacology and therapeutics. New York: Churchill Livingstone Inc; 1994. p. 765-78.
  • Zelis R, Flaim SF, Liedtke AJ, Nellis SH. Cardiocirculatory dynamics in the normal and failing heart. Ann Rev Physiol 1981; 43: 455-76.
  • Clemensen P, Christensen P, Norsk P, Gronlund J. A modified photo- and magnetoacoustic multigas analyzer applied in gas exchange measurements. J Appl Physiol 1994; 76: 2832-9.
  • Gabrielsen A, Videbk R, Schou M, Damgaard M, Kastrup J, Norsk P. Non-invasive measurement of cardiac output in heart failure patients using a new foreign gas rebreathing technique. Clin Sei 2002; 102: 247-52.
  • Berglund E, Birath G, Bjure J, Grimby G, Kjellmer I, Sandqvist L, Söderhobn B. Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age. Acta Med Scand 1963; 173: 185-98.
  • Kappelgaard AM, Nielsen MD, Giese J. Measurement of angiotensin II in human plasma: technical modifications and practical experience. CHn Chim Acta 1976; 67: 299-306.
  • Knudsen JH, Christensen NJ, Bratholm P. Lymphocyte norepinephrine and epinephrine, but not plasma catecholamines, predict lymphocyte cAMP production. Life Sei 1996; 59: 639-47.
  • Matsukawa T, Gotoh E, Minamisawa K, Kihara M, Ueda S-I, Shionoiri H, Ishii M. Effects of angiotensin II on muscle sympathetic nerve activity in humans. Am J Physiol Regulatory Integrative Comp. Physiol 1991; 261: R690-R6.
  • Dzau VJ, Packer M, Lilly LS, Swartz SL, Hollenberg NK, Williams GH. Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponatremia. N Engl J Med 1984; 310: 347-52.
  • Sun Y, Ramires FJA, Weber KT. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res 1997; 35: 138-47.
  • Dickstein K, Aarsland T, Hall C. Plasma N-terminal atrial natriuretic factor: a predictor of survival in patients with congestive heart failure. J Cardiac Fail 1997; 3: 83-9.
  • Atlas SA, Laragh JH. Atrial natriuretic peptide: A new factor in hormonal control of blood pressure and electrolyte homeostasis. Ann Rev Med 1986; 37: 397-4.
  • Dzau VJ. Vascular and renal prostaglandins as counter-regulatory systems in heart failure. Eur Heart 1988; 9 Suppl H: 15-9.
  • Cheng C-P, Onishi K, Ohte N, Suzuki M, Little WC. Functional effects of endogenous bradykinin in congestive heart failure. J Am Coll Cardiol 1998; 31: 1679-86.
  • Bonner G, Preis S, Schunk U, Wagmann M, Chrosch R, Toussaint C. Effect of bradykinin on arteries and veins in systemic and pulmonary circulation. J Cardiovasc Pharmacol 1992; 20 Suppl 9: S21-S7.
  • Elsner D, Muntze A, Kromer EP, Riegger GA. Prostaglandin E2 in dogs with heart failure: hemodynamic, hormonal, and renal effects. J Cardiovasc Pharmacol 1992; 20: 547-53.
  • Nishimura H, Kubo S, Ueyama M, Kubota J, Kawamura K. Peripheral hemodynamic effects of captopril in patients with congestive heart failure. Am Heart J 1989; 117: 100-105.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.